202 related articles for article (PubMed ID: 1704362)
1. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
[TBL] [Abstract][Full Text] [Related]
2. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Coia LR; Engstrom PF; Paul A
J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
[TBL] [Abstract][Full Text] [Related]
3. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction.
Coia LR; Paul AR; Engstrom PF
Cancer; 1988 Feb; 61(4):643-9. PubMed ID: 3338031
[TBL] [Abstract][Full Text] [Related]
4. Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma.
Chan A; Wong A; Arthur K
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):59-65. PubMed ID: 2492271
[TBL] [Abstract][Full Text] [Related]
5. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
John M; Flam M; Wittlinger P; Mowry PA
Am J Clin Oncol; 1987 Aug; 10(4):310-6. PubMed ID: 2441591
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of combined radiotherapy and chemotherapy for esophageal carcinoma.
Coia LR; Engstrom PF; Paul A; Gallagher MJ; Stoll D; Catalano R; Richter MP
Am J Clin Oncol; 1984 Dec; 7(6):653-9. PubMed ID: 6084954
[TBL] [Abstract][Full Text] [Related]
7. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
[TBL] [Abstract][Full Text] [Related]
8. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma.
Keane TJ; Harwood AR; Elhakim T; Rider WD; Cummings BJ; Ginsberg RJ; Cooper JC
Radiother Oncol; 1985 Nov; 4(3):205-10. PubMed ID: 3936125
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the oesophagus treated with radiation and 5-fluorouracil, with and without mitomycin C.
Brierley J; Wong CS; Cummings B; Catton P; Ringash J; Catton C; McLean M; Keane T; Panzarella T
Clin Oncol (R Coll Radiol); 2001; 13(3):157-63. PubMed ID: 11527287
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Wolf M; Zehentmayr F; Niyazi M; Ganswindt U; Haimerl W; Schmidt M; Hölzel D; Belka C
Strahlenther Onkol; 2010 Jul; 186(7):374-81. PubMed ID: 20582393
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
[TBL] [Abstract][Full Text] [Related]
13. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
[TBL] [Abstract][Full Text] [Related]
14. Nonoperative therapy for squamous-cell cancer of the esophagus.
Leichman L; Herskovic A; Leichman CG; Lattin PB; Steiger Z; Tapazoglou E; Rosenberg JC; Arbulu A; Asfaw I; Kinzie J
J Clin Oncol; 1987 Mar; 5(3):365-70. PubMed ID: 2434626
[TBL] [Abstract][Full Text] [Related]
15. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
Stewart FM; Harkins BJ; Hahn SS; Daniel TM
Cancer; 1989 Aug; 64(3):622-8. PubMed ID: 2501018
[TBL] [Abstract][Full Text] [Related]
17. The use of mitomycin in esophageal cancer.
Coia LR
Oncology; 1993 Apr; 50 Suppl 1():53-60. PubMed ID: 8483558
[TBL] [Abstract][Full Text] [Related]
18. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
[TBL] [Abstract][Full Text] [Related]
20. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
